Search research articles
Contact Us
Filters
Showing results (211-220 of 368) with videos related to
Page
of 37
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 25, 2014
Polymorphisms and haplotypes of the UDP-glucuronosyltransferase 2B7 gene promoter
Dong Gui Hu, Robyn Meech, Lu Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 2018
Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma
Dong Gui Hu, Shashikanth Marri, Ross A McKinnon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 26, 2015
Induction of human UDP-Glucuronosyltransferase 2B7 gene expression by cytotoxic anticancer drugs in liver cancer HepG2 cells
Dong Gui Hu, Peter I Mackenzie, Lu Lu, et al.
Molecular Pharmacology
|
August 6, 2015
Suppression of Cytochrome P450 3A4 Function by UDP-Glucuronosyltransferase 2B7 through a Protein-Protein Interaction: Cooperative Roles of the Cytosolic Carboxyl-Terminal Domain and the Luminal Anchoring Region
Yuu Miyauchi, Kiyoshi Nagata, Yasushi Yamazoe, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 24, 2017
Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
Ayumi Kurita, Yuu Miyauchi, Shin'ichi Ikushiro, et al.
Japanese Journal of Cancer Research : Gann
|
February 25, 1998
The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro
T Takahashi, Y Fujiwara, M Yamakido, et al.
Toxicology and Applied Pharmacology
|
September 15, 2004
Regulation of UDP glucuronosyltransferases in the gastrointestinal tract
Philip A Gregory, Rikke H Lewinsky, Dione A Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 14, 2018
Drug and Chemical Glucosidation by Control Supersomes and Membranes from <i>Spodoptera frugiperda</i> (Sf) 9 Cells: Implications for the Apparent Glucuronidation of Xenobiotics by UDP-glucuronosyltransferase 1A5
Nuy Chau, Leyla Kaya, Benjamin C Lewis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 14, 2017
Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer Cells
Apichaya Chanawong, Peter I Mackenzie, Ross A McKinnon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 16, 2003
Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7
Andrew N Stone, Peter I Mackenzie, Aleksandra Galetin, et al.
Page
of 37
Search research articles
Search
Showing results (211-220 of 368) with videos related to
Sort By:
Page
of 37
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 25, 2014
Polymorphisms and haplotypes of the UDP-glucuronosyltransferase 2B7 gene promoter
Dong Gui Hu, Robyn Meech, Lu Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 2018
Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma
Dong Gui Hu, Shashikanth Marri, Ross A McKinnon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 26, 2015
Induction of human UDP-Glucuronosyltransferase 2B7 gene expression by cytotoxic anticancer drugs in liver cancer HepG2 cells
Dong Gui Hu, Peter I Mackenzie, Lu Lu, et al.
Molecular Pharmacology
|
August 6, 2015
Suppression of Cytochrome P450 3A4 Function by UDP-Glucuronosyltransferase 2B7 through a Protein-Protein Interaction: Cooperative Roles of the Cytosolic Carboxyl-Terminal Domain and the Luminal Anchoring Region
Yuu Miyauchi, Kiyoshi Nagata, Yasushi Yamazoe, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 24, 2017
Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
Ayumi Kurita, Yuu Miyauchi, Shin'ichi Ikushiro, et al.
Japanese Journal of Cancer Research : Gann
|
February 25, 1998
The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro
T Takahashi, Y Fujiwara, M Yamakido, et al.
Toxicology and Applied Pharmacology
|
September 15, 2004
Regulation of UDP glucuronosyltransferases in the gastrointestinal tract
Philip A Gregory, Rikke H Lewinsky, Dione A Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 14, 2018
Drug and Chemical Glucosidation by Control Supersomes and Membranes from <i>Spodoptera frugiperda</i> (Sf) 9 Cells: Implications for the Apparent Glucuronidation of Xenobiotics by UDP-glucuronosyltransferase 1A5
Nuy Chau, Leyla Kaya, Benjamin C Lewis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 14, 2017
Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer Cells
Apichaya Chanawong, Peter I Mackenzie, Ross A McKinnon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 16, 2003
Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7
Andrew N Stone, Peter I Mackenzie, Aleksandra Galetin, et al.
Page
of 37